House Health and Human Services committee advances six health bills, including opioid antagonist expansion and maternal-monitoring pilot

At a meeting of the House Health and Human Services Committee's full committee, members advanced six bills referred from the health subcommittee, voting either to pass the bills or to report them to the Appropriations Committee.

The measures advanced address a range of issues: expanding who may dispense opioid antagonists beyond naloxone, establishing a Department of Health menstrual-health program, creating a remote patient-monitoring pilot for maternal hypertension and diabetes, allowing certain in-system distribution of compounded drugs, and removing a funeral-director monthly reporting requirement. Most measures passed or were reported out unanimously; one opioid-related bill passed 17–1.

Why this matters: the bills affect clinical practice rules, public-health programs and data collection, and licensing or reporting requirements for private providers. Two measures were reported to the Appropriations Committee for consideration of funding and implementation details.

House Bill highlights and outcomes

House Bill 1552 (patron: Delegate Wiley) — The transcript did not include the bill's substantive text. The health subcommittee recommended reporting the measure (subcommittee vote reported as 7–0). The full committee recorded a final vote of 17–0 to report the bill from the subcommittee. The substitute motion was offered by Delegate Hope on the committee floor and seconded (seconder not named in the transcript). HB…